Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aspen Acquires AstraZeneca Anesthetics Portfolio Ex-US

Executive Summary

Continuing its divesture of non-core assets, AstraZeneca PLC has licensed rights to its global anesthetics portfolio outside the US to South Africa's Aspen Global Incorporated


Related Content

Deal Watch: AstraZeneca Offloads US Anesthesiology Portfolio To Aspen
Biopharma Quarterly Dealmaking Statistics, Q2 2016
AstraZeneca’s Business Development Head Grady Outlines Strategy Mix
AstraZeneca's 'Clear-Out' Strategy Sees Gout Drug Go To Grunenthal


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts